Application Sponsors
ANDA 206812 | JIANGSU HENGRUI MED | |
Marketing Status
Prescription | 001 |
Prescription | 002 |
Prescription | 003 |
Prescription | 004 |
Application Products
001 | INJECTABLE;SUBCUTANEOUS | 2.5MG/0.5ML | 0 | FONDAPARINUX SODIUM | FONDAPARINUX SODIUM |
002 | INJECTABLE;SUBCUTANEOUS | 5MG/0.4ML | 0 | FONDAPARINUX SODIUM | FONDAPARINUX SODIUM |
003 | INJECTABLE;SUBCUTANEOUS | 7.5MG/0.6ML | 0 | FONDAPARINUX SODIUM | FONDAPARINUX SODIUM |
004 | INJECTABLE;SUBCUTANEOUS | 10MG/0.8ML | 0 | FONDAPARINUX SODIUM | FONDAPARINUX SODIUM |
FDA Submissions
UNKNOWN; | ORIG | 1 | AP | 2018-05-15 | STANDARD |
Submissions Property Types
TE Codes
001 | Prescription | AP |
002 | Prescription | AP |
003 | Prescription | AP |
004 | Prescription | AP |
CDER Filings
JIANGSU HENGRUI MED
cder:Array
(
[0] => Array
(
[ApplNo] => 206812
[companyName] => JIANGSU HENGRUI MED
[docInserts] => ["",""]
[products] => [{"drugName":"FONDAPARINUX SODIUM","activeIngredients":"FONDAPARINUX SODIUM","strength":"2.5MG\/0.5ML","dosageForm":"INJECTABLE;SUBCUTANEOUS","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"FONDAPARINUX SODIUM","activeIngredients":"FONDAPARINUX SODIUM","strength":"5MG\/0.4ML","dosageForm":"INJECTABLE;SUBCUTANEOUS","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"FONDAPARINUX SODIUM","activeIngredients":"FONDAPARINUX SODIUM","strength":"7.5MG\/0.6ML","dosageForm":"INJECTABLE;SUBCUTANEOUS","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"FONDAPARINUX SODIUM","activeIngredients":"FONDAPARINUX SODIUM","strength":"10MG\/0.8ML","dosageForm":"INJECTABLE;SUBCUTANEOUS","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"05\/15\/2018","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
[supplements] =>
[actionDate] => 2018-05-15
)
)